This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Università Degli Studi Di Roma "La Sapienza". Active years: 2021.
Company Filing History:
1 out of 146 
1 out of 63 
Years Active: 2021
Title: Rocco Palermo: Innovator in Cancer Treatment
Introduction
Rocco Palermo is a notable inventor based in Rome, Italy. He has made significant contributions to the field of oncology, particularly in the treatment of T-cell acute lymphoblastic leukemia (T-ALL). His innovative work has the potential to impact the lives of many patients suffering from this aggressive form of cancer.
Latest Patents
Rocco Palermo holds a patent for "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia." This patent describes compounds of formula (I) that exhibit anti-tumor activity, specifically targeting T-ALL. His research in this area highlights the importance of developing effective treatments for challenging medical conditions.
Career Highlights
Throughout his career, Rocco has worked with prestigious institutions, including the Università Degli Studi Di Roma "La Sapienza" and the Fondazione Istituto Italiano Di Tecnologia. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Rocco has collaborated with talented individuals such as Deborah Quaglio and Isabella Screpanti. These partnerships have fostered a productive environment for innovation and research in cancer treatment.
Conclusion
Rocco Palermo's work in developing Notch inhibitors represents a significant advancement in the fight against T-cell acute lymphoblastic leukemia. His dedication to research and collaboration with esteemed institutions and colleagues underscores his commitment to improving patient outcomes.